Table 2 Participants and non-participants
Variable | Participants, n = 118 (100%) | Non-participants, n = 155 (100%) |
|---|---|---|
Sex | ||
Women | 77 (65.3%) | 77 (49.7%) |
Men | 41 (34.8%) | 78 (50.3%) |
Age | ||
30-50 years | 5 (4.2%) | 9 (5.8%) |
51-70 years | 67 (56.8%) | 51 (32.9%) |
71-90 years | 45 (38.1%) | 90 (58.1%) |
>90 years | 1 (0.9%) | 5 (3.2%) |
Cancer types | ||
Lung cancer | 37 (31.4%) | 50 (32.3%) |
Breast cancer | 21 (17.8%) | 22 (14.2%) |
Colon cancer | 18 (15.3%) | 29 (18.7%) |
Pancreatic cancer | 8 (6.8%) | 7 (4.5%) |
Rectal cancer | 7 (5.9%) | 17 (11.0%) |
Myeloma | 7 (5.9%) | 2 (1.3%) |
Non-Hodgkin’s Lymphoma | 6 (5.1%) | 8 (5.2%) |
Ovarian cancer | 2 (1.7%) | 2 (1.3%) |
Melanoma | 1 (0.8%) | 2 (1.3%) |
Leukemia | 1 (0.8%) | 7 (4.5%) |
Endometrial cancer | 1 (0.8%) | 0 (0.0%) |
Prostate cancer | 0 (0.0%) | 2 (1.3%) |
Other | 9 (7.6%) | 7 (4.5%) |